Reduction of vitreous loss in cataract surgery.
D000086:Acetazolamide / Q000627:therapeutic use; D002387:Cataract Extraction / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008353:Mannitol / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D014508:Urea / Q000627:therapeutic use*; D014822:Vitreous Body
D008353:Mannitol; D014508:Urea; D000086:Acetazolamide